NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX) today announced that it will be showcasing progress with its advanced Genomic Antibody TechnologyTM (GATTM) data package this week’s BIO International Convention, one of the largest global partnering events for the biotechnology industry. Advanced GAT is the next generation of the Company’s well-established and successfully marketed proprietary DNA-immunization-based technology. The 2012 event is taking place at the Boston Convention & Exhibition Center in Boston, MA, on June 18-21.
